Evaluation of a computer-assisted diagnosis system, BONENAVI version 2, for bone scintigraphy in cancer patients in a routine clinical setting

Annals of Nuclear Medicine

Volumn 29, Issue 2, 2015, Pages 138-148

  Koizumi, Mitsuru ^a   Wagatsuma, Kei ^a   Miyaji, Noriaki ^a   Murata, Taisuke ^a   Miwa, Kenta ^a   Takiguchi, Tomohiro ^a   Makino, Tomoko ^a   Koyama, Masamichi ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Bone scan; BONENAVI version 2; Computer aided diagnosis; Skeletal metastasis

Indexed keywords

MEDRONATE TECHNETIUM TC 99M;

ARTICLE; ARTIFICIAL NEURAL NETWORK; BONE ATROPHY; BONE METASTASIS; BONE SCINTISCANNING; BONE TUMOR; BREAST CANCER; CANCER PATIENT; CANCER SCINTISCANNING; CLINICAL EVALUATION; COHORT ANALYSIS; COMPRESSION FRACTURE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED DIAGNOSIS SYSTEM; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED SCINTIGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER SYSTEM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FIBROUS DYSPLASIA; FOLLOW UP; GAMMA CAMERA; HUMAN; IMAGE ANALYSIS; IMAGING SOFTWARE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PET-CT SCANNER; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; SAPHO SYNDROME; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; BONE; COMPUTER ASSISTED DIAGNOSIS; EVALUATION STUDY; LABORATORY DIAGNOSIS; PATHOLOGY; PROCEDURES; RADIOGRAPHY; SCINTISCANNING; SECONDARY;

BONE AND BONES; BONE NEOPLASMS; DIAGNOSIS, COMPUTER-ASSISTED; FALSE NEGATIVE REACTIONS; HUMANS; MALE; NEURAL NETWORKS (COMPUTER); TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 84925536821     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-014-0921-y     Document Type: Article

References (16)

1. Imbriaco M, Larson SM, Yeung HW, Mawlawi OR, Erdi Y, Venkatraman ES, et al. A new parameter for measuring metastatic bone involvement by prostate cancer: the bone scan index. Clin Cancer Res. 1998;4:1765–72.
2. Sadik M, Jakobsson D, Olofsson F, Ohlsson M, Suurkula M, Edenbrandt L. A new computer-based decision-support system for the interpretation of bone scans. Nucl Med Commun. 2006;27:417–23.
3. Sadik M, Suurkula M, Hoglund P, Jarund A, Edenbrandt L. Quality of planar whole-body bone scan interpretation—a nationwide survey. Eur J Nucl Med Mol Imaging. 2008;35:1464–72.
4. Sadik M, Hamadeh I, Nordblom P, Suurkula M, Hoglund P, Phlsson M, et al. Computer-assisted interpretation of planar whole-body bone scans. J Nucl Med. 2008;49:1958–65.
5. Horikoshi H, Kikuchi A, Onoguchi M, Sjostrand K, Edenbrandt L. Computer-aided diagnosis system for bone scintigrams from Japanese patients: importance of training database. Ann Nucl Med. 2012;26:622–6.
6. Nakajima K, Nakajima Y, Horikoshi H, Ueno M, Wakabayashi H, Shiga T, et al. Enhanced diagnostic accuracy of quantitative bone scan using an artificial neural network system: a Japanese multi-center database project. Eur J Nucl Med Mol Imaging Res. 2013;3:83 published online.
7. Ulmert D, Kabateh R, Fox JJ, Savage C, Evans MJ, Lilja H, et al. A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the bone scan index. Eur Urol. 2012;62:78–84.
8. Yamaguchi T, Tamaki K, Yamato M, Honma K, Ueda Y, Saotome K. Intertrabecular pattern of tumors metastatic to bone. Cancer. 1996;78:1384–94.
9. Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd B, Soloway S, et al. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer. 1988;61:195–202.
10. Meirelles GSP, Schoder H, Ravizzini GC, Gonen M, Fox JJ, Humm J, et al. Prognostic value of baseline F-18 fluorodeoxyglucose positron emission tomography and Tc-99m MDP bone scan in progressing metastatic prostate cancer. Clin Cancer Res. 2010;16:6093–9.
11. Dennis ER, Jia X, Mezheritskiy IS, Stephenson RD, Schoder H, Fox JJ, et al. Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer. J Clin Oncol. 2012;30:519–24.
12. Tokuda O, Harada Y, Ohishi Y, Matsunaga N, Edenbrandt L. Investigation of computer-aided diagnosis system for bone scans: a retrospective analysis in 406 patients. Ann Nucl Med. 2014;28:329–39.
13. Evangelista L, Panunzio A, Polverosi R, Ferretti A, Chondrogiannis S, Pomerri F, et al. Early bone marrow metastasis detection: the additional value of FDG-PET/CT vs. CT imaging. Biomed Pharmacother. 2012;66:448–53.
14. Pollen JJ, Witztum KF, Ashbum WL. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer. AJR. 1984;142:773–6.
15. Lemieux J, Guimond J, Laberge F, St-Pierre C, Cormier Y. The bone scan flare phenomenon in non-small-cell lung cancer. Clin Nucl Med. 2002;27:486–9.
16. Koizumi M, Matsumoto S, Takahashi S, Yamashita T, Ogata E. Bone metabolic markers are useful in the diagnosis of bone scan flare phenomenon in bone metastases from breast cancers. Clin Nucl Med. 1999;24:15–20.